Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516199 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Biomarkers in Drug Development: A Handbook of Practice, Application, and Strategy

John Wiley and Sons Ltd, March 2010, Pages: 760


  Description  
   Table of Contents   
   Author   
    
    
     
  Enquire before Buying   
  Send to a Friend   

Discover how biomarkers can boost the success rate of drug development efforts

As pharmaceutical companies struggle to improve the success rate and cost-effectiveness of thedrug development process, biomarkers have emerged as a valuable tool. This book synthesizes and reviews the latest efforts to identify, develop, and integrate biomarkers as a key strategy in translational medicine and the drug development process. Filled with case studies, the book demonstrates how biomarkers can improve drug development timelines, lower costs, facilitate better compound selection, reduce late-stage attrition, and open the door to personalized medicine.

Biomarkers in Drug Development is divided into eight parts:

- Part One offers an overview of biomarkers and their role in drug development.

- Part Two highlights important technologies to help researchers identify new biomarkers.

- Part Three examines the characterization and validation process for both drugs and diagnostics, and provides practical advice on appropriate statistical methods to ensure that biomarkers fulfill their intended purpose.

- Parts Four through Six examine the application of biomarkers in discovery, preclinical safety assessment, clinical trials, and translational medicine.

- Part Seven focuses on lessons learned and the practical aspects of implementing biomarkers in drug development programs.

- Part Eight explores future trends and issues, including data integration, personalized medicine, and ethical concerns.

Each of the thirty-eight chapters was contributed by one or more leading experts, including scientists from biotechnology and pharmaceutical firms, academia, and the U.S. Food and Drug Administration. Their contributions offer pharmaceutical and clinical researchers the most up-to-date understanding of the strategies used for and applications of biomarkers in drug development.



Customers who bought this item also bought

Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly

Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs

Personalized Medicine - Scientific and Commercial Aspects

Biomarkers: Applications and Trends

Enabling Innovation: Drug Development Through Biomarker Validation and Qualification

Biomarkers: In Medicine, Drug Discovery, and Environmental Health

Translational Medicine in Biopharmaceutical R&D: Enabling R&D Optimization and Early Detection of Potential Failures

Flow Cytometry in Drug Discovery and Development

Cancer Biomarkers: New Tools for Transforming Cancer Management

Companion Biomarkers in Drug Development



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds